San Antonio, TXNCT05673408Now EnrollingIRB Ready

Critical Illness Clinical Trial in San Antonio, TX

Access cutting-edge critical illness treatment through this clinical trial at a research site in San Antonio. Study-provided care at no cost to qualified participants.

Sponsored by Philips Clinical & Medical Affairs Global

Quick Self-Assessment

See if you qualify for this San Antonio location

Preparing your pre-screening questions…

Expert Care in San Antonio

Access critical illness specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related critical illness treatment provided free

Apply for This San Antonio Location

Check if you qualify for this critical illness clinical trial in San Antonio, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to San Antonio

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit San Antonio site if eligible
  4. 4Begin participation

About This Critical Illness Study in San Antonio

The purpose of this study is to compare measurements of blood pressure (BP) between the Philips non-invasive blood pressure (NIBP) system (including NIBP cuff and portable patient monitor) and invasive radial for Subject Group 2 and 3, and radial or umbilical arterial line for neonates (A-line) in critical care patients.

Sponsor: Philips Clinical & Medical Affairs Global

Who Can Participate

Inclusion Criteria

Patient admitted into the NICU, PICU, ICU, or OR (operating room)
Adult aged 18 years and older, or parent/legal guardian of minor, willing and able to understand and provide informed consent/assent
Indication for NIBP cuff
Indication for radial arterial line for Subject Group 2 and Subject Group 3, and radial or umbilical arterial line for Subject Group 1
Meet the following stratification criteria across the study: Stratification (per the ISO 81060-2:2018/Amd-2:2024):
Subject Group 1:
At least 3 patients shall be \<1000 g in weight
At least 3 patients shall be 1000 to 2000 g in weight
At least 3 patients shall be \> 2000 g in weight
At least 3 patients shall be ≥ 29 days and \< 1 year of age
At least 3 patients shall be ≥ 1 year and \< 3 years of age
The remaining patients may be from any of the above age or weight groups in order to complete the sample size
A patient can be in more than one category simultaneously
Subject Group 2:
At least 30% male, 30% female
Limb circumference distributed as specified in ISO81060-2:2018/Amd2:2024.
Subject Group 3:
At least 30% male, 30% female
Limb circumference distributed as specified in ISO81060- 2:2018/Amd-2:2024.
At least 10% SBP ≤ 100mmHg
At least 10% SBP ≥ 160mmHg
At least 10% DBP ≤ 70mmHg
At least 10% DBP ≥ 85mmHg

Exclusion Criteria

Inability to place the study device appropriately due to patient's anatomy or condition
Known pregnancy or lactating women (self-report)
Patients treated with an intra-aortic balloon pump
Aortic and mitral regurgitation (\> 2 nd degree)
Measurements taken in the lateral position
Currently participating in another clinical trial with any product, treatment and/or medication that clinically interferes with the study endpoint(s)
If valid SBP reference measurements for lateral difference is \> 15 mmHg (except for neonates with umbilical A-line)
If valid DBP reference measurements for lateral difference is \> 10 mmHg (except for neonates with umbilical A-line)
At the Principal Investigator's discretion, subject does not qualify to participate in the study for any reasons that are not mentioned above

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in San Antonio?

Yes, this clinical trial (NCT05673408) has an active research site in San Antonio, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Critical Illness Treatment Options in San Antonio, TX

If you're searching for critical illness treatment options in San Antonio, TX, this clinical trial (NCT05673408) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our San Antonio research site is actively enrolling participants for this clinical trial. You'll receive care from experienced critical illness specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all critical illness clinical trials near you to find additional studies recruiting in your area.

More Interstitial Cystitis Trials in San Antonio, TX

See all interstitial cystitis clinical trials recruiting in San Antonio — not just this study.

Browse Interstitial Cystitis Trials in San Antonio →

Browse More Trials by Condition

Interstitial Cystitis TrialsLupus Nephritis TrialsAll Conditions →

Ready to Join in San Antonio?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · San Antonio, TX